Cargando…
Pericardial Effusion Secondary to Nilotinib in an Elderly Patient With Chronic Myelogenous Leukemia
Tyrosine kinase inhibitors (TKIs) are the first-line treatment for patients with chronic myelogenous leukemia (CML). Serositis, including pleural and pericardial effusions, is a frequent adverse event with some TKIs while less frequent with others. We present a case of a 76-year-old woman with CML o...
Autores principales: | Arora, Geetika, Adinugraha, Paulus, Aijaz, Amna, Vargas Pelaez, Alvaro, Rachko, Maurice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072281/ https://www.ncbi.nlm.nih.gov/pubmed/35530911 http://dx.doi.org/10.7759/cureus.23855 |
Ejemplares similares
-
Extramedullary Acute Myeloid Leukemia Presenting With Pericardial Effusion and Arrhythmias
por: Najam, Usman S, et al.
Publicado: (2023) -
Dasatinib-Induced Pleural and Pericardial Effusions
por: Hailan, Yousef M, et al.
Publicado: (2021) -
Pericardial Effusion Secondary to Amoebic Liver Abscess: A Rare Complication
por: Raza, Mohammad, et al.
Publicado: (2020) -
Pericardial Effusion: Rare Adverse Effect of Clozapine
por: Bath, Anandbir S, et al.
Publicado: (2019) -
Subacute Cardiac Tamponade With Massive Pericardial Effusion
por: Hein, Aung, et al.
Publicado: (2022)